Literature DB >> 17157209

Activation of T lymphocytes and the role of the adapter LAT.

Enrique Aguado1, Mario Martínez-Florensa, Pedro Aparicio.   

Abstract

The adapter molecule LAT (Linker for the Activation of T cells) is a membrane protein that becomes phosphorylated on conserved tyrosine residues upon TCR/CD3 complex engagement in T lymphocytes. Tyrosine phosphorylation of this adapter recruits to the membrane many signaling proteins through the interaction with the phosphotyrosine binding domains of these proteins, allowing the activation of several intracellular signaling pathways. Initial studies performed in T cell lines suggested that the adapter LAT acts primarily as a platform for the distribution of activation signals coming from the TCR/CD3 complex, and the phenotype of LAT deficient mice, in which T cell development is arrested at an early stage, supported this "activatory" function. However, the analysis of several knock-in mice strains in which some tyrosine residues have been mutated, has revealed the development of lymphoproliferative disorders caused by polyclonal T lymphocytes producing high titers of T helper-type 2 (T(H)2) cytokines. Very recently, it has been demonstrated that raft localization of LAT is altered in anergic T lymphocytes. Therefore, LAT show unexpected regulatory functions in T cell development and homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157209     DOI: 10.1016/j.trim.2006.09.013

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  6 in total

Review 1.  Scaffold proteins and immune-cell signalling.

Authors:  Andrey S Shaw; Erin L Filbert
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

2.  Pre-existing clusters of the adaptor Lat do not participate in early T cell signaling events.

Authors:  David J Williamson; Dylan M Owen; Jérémie Rossy; Astrid Magenau; Matthias Wehrmann; J Justin Gooding; Katharina Gaus
Journal:  Nat Immunol       Date:  2011-06-05       Impact factor: 25.606

3.  Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.

Authors:  Suman Kundu; Keke Fan; Mingli Cao; Daniel J Lindner; Zhizhaung Joe Zhao; Ernest Borden; Taolin Yi
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

4.  Beta-catenin inhibits T cell activation by selective interference with linker for activation of T cells-phospholipase C-γ1 phosphorylation.

Authors:  Gregory Driessens; Yan Zheng; Frederick Locke; Judy L Cannon; Fotini Gounari; Thomas F Gajewski
Journal:  J Immunol       Date:  2010-12-13       Impact factor: 5.422

5.  Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.

Authors:  Nayoung Kim; Woosung Chung; Hye Hyeon Eum; Hae-Ock Lee; Woong-Yang Park
Journal:  PLoS One       Date:  2019-05-17       Impact factor: 3.240

6.  A Stretch of Negatively Charged Amino Acids of Linker for Activation of T-Cell Adaptor Has a Dual Role in T-Cell Antigen Receptor Intracellular Signaling.

Authors:  Mikel M Arbulo-Echevarria; Isaac Narbona-Sánchez; Cecilia M Fernandez-Ponce; Inmaculada Vico-Barranco; Mª Dolores Rueda-Ygueravide; Michael L Dustin; Arkadiusz Miazek; Mª Carmen Duran-Ruiz; Francisco García-Cózar; Enrique Aguado
Journal:  Front Immunol       Date:  2018-02-02       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.